RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Elevation Oncology Stock

Elevation Oncology Equity 2024

Elevation Oncology Equity

54.81 M USD

Ticker

ELEV

ISIN

US28623U1016

In 2024, Elevation Oncology's equity was 54.81 M USD, a 11.86% increase from the 49 M USD equity in the previous year.

Elevation Oncology Aktienanalyse

What does Elevation Oncology do?

Elevation Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Elevation Oncology's Equity

Elevation Oncology's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Elevation Oncology's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Elevation Oncology's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Elevation Oncology's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Elevation Oncology’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Elevation Oncology stock

What is the equity of Elevation Oncology this year?

Elevation Oncology has equity of 54.81 M USD this year.

What was the equity of Elevation Oncology compared to the previous year?

The equity of Elevation Oncology has increased/decreased by 11.86% increased compared to the previous year.

What impact does a high equity have on investors of Elevation Oncology?

A high equity is advantageous for investors of Elevation Oncology as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Elevation Oncology?

A low equity can be a risk for investors of Elevation Oncology, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Elevation Oncology affect the company?

An increase in equity of Elevation Oncology can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Elevation Oncology affect the company?

A reduction in equity of Elevation Oncology can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Elevation Oncology?

Some factors that can affect the equity of Elevation Oncology include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Elevation Oncology so important for investors?

The equity of Elevation Oncology is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Elevation Oncology take to change the equity?

To change equity, Elevation Oncology can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Elevation Oncology pay?

Over the past 12 months, Elevation Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Elevation Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Elevation Oncology?

The current dividend yield of Elevation Oncology is .

When does Elevation Oncology pay dividends?

Elevation Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Elevation Oncology?

Elevation Oncology paid dividends every year for the past 0 years.

What is the dividend of Elevation Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Elevation Oncology located?

Elevation Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Elevation Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Elevation Oncology from 7/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/27/2024.

When did Elevation Oncology pay the last dividend?

The last dividend was paid out on 7/27/2024.

What was the dividend of Elevation Oncology in the year 2023?

In the year 2023, Elevation Oncology distributed 0 USD as dividends.

In which currency does Elevation Oncology pay out the dividend?

The dividends of Elevation Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Elevation Oncology

Our stock analysis for Elevation Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elevation Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.